Sign In
Buy KALV
$14.86
+1.24 (+9.10%)
At Close: Nov 17, 2025
KalVista Pharmaceuticals Earnings Calls
Sep 30, 2025
(Upcoming)
| Release date | Dec 11, 2025 |
| EPS estimate | -$1.06 |
| EPS actual | - |
| Revenue estimate | 6.033M |
| Revenue actual | - |
| Expected change | +/- 9.53% |
Jul 31, 2025
-$1.12 (-23.08%)
| Release date | Sep 11, 2025 |
| EPS estimate | -$0.91 |
| EPS actual | -$1.12 |
| EPS Surprise | -23.08% |
| Revenue estimate | 12.614M |
| Revenue actual | 1.426M |
| Revenue Surprise | -88.70% |
Apr 30, 2025
-$0.99 (-28.57%)
| Release date | Jul 10, 2025 |
| EPS estimate | -$0.770 |
| EPS actual | -$0.99 |
| EPS Surprise | -28.57% |
| Revenue estimate | 4.202M |
| Revenue actual | - |
Jan 31, 2025
-$0.92 (-3.37%)
| Release date | Mar 12, 2025 |
| EPS estimate | -$0.89 |
| EPS actual | -$0.92 |
| EPS Surprise | -3.37% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for KalVista Pharmaceuticals
Below you can see how KALV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jan 31, 2025
Missed
| Release date | Mar 12, 2025 |
| Price on release | $12.45 |
| EPS estimate | -$0.89 |
| EPS actual | -$0.92 |
| EPS surprise | -3.37% |
| Date | Price |
|---|---|
| Mar 06, 2025 | $11.98 |
| Mar 07, 2025 | $11.92 |
| Mar 10, 2025 | $11.99 |
| Mar 11, 2025 | $12.43 |
| Mar 12, 2025 | $12.45 |
| Mar 13, 2025 | $12.25 |
| Mar 14, 2025 | $12.60 |
| Mar 17, 2025 | $12.49 |
| Mar 18, 2025 | $12.37 |
| 4 days before | 3.92% |
| 4 days after | -0.643% |
| On release day | -1.61% |
| Change in period | 3.26% |
Apr 30, 2025
Missed
| Release date | Jul 10, 2025 |
| Price on release | $15.51 |
| EPS estimate | -$0.770 |
| EPS actual | -$0.99 |
| EPS surprise | -28.57% |
| Date | Price |
|---|---|
| Jul 03, 2025 | $11.98 |
| Jul 07, 2025 | $15.06 |
| Jul 08, 2025 | $14.95 |
| Jul 09, 2025 | $15.99 |
| Jul 10, 2025 | $15.51 |
| Jul 11, 2025 | $14.52 |
| Jul 14, 2025 | $15.22 |
| Jul 15, 2025 | $15.17 |
| Jul 16, 2025 | $15.79 |
| 4 days before | 29.47% |
| 4 days after | 1.81% |
| On release day | -6.38% |
| Change in period | 31.80% |
Jul 31, 2025
Missed
| Release date | Sep 11, 2025 |
| Price on release | $14.81 |
| EPS estimate | -$0.91 |
| EPS actual | -$1.12 |
| EPS surprise | -23.08% |
| Date | Price |
|---|---|
| Sep 05, 2025 | $15.82 |
| Sep 08, 2025 | $15.96 |
| Sep 09, 2025 | $15.61 |
| Sep 10, 2025 | $15.39 |
| Sep 11, 2025 | $14.81 |
| Sep 12, 2025 | $14.01 |
| Sep 15, 2025 | $13.62 |
| Sep 16, 2025 | $13.50 |
| Sep 17, 2025 | $13.38 |
| 4 days before | -6.38% |
| 4 days after | -9.66% |
| On release day | -5.40% |
| Change in period | -15.42% |
Sep 30, 2025
(Upcoming)
| Release date | Dec 11, 2025 |
| Price on release | - |
| EPS estimate | -$1.06 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $11.47 |
| Nov 12, 2025 | $13.34 |
| Nov 13, 2025 | $13.09 |
| Nov 14, 2025 | $13.62 |
| Nov 17, 2025 | $14.86 |
KalVista Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for KALV?
KalVista Pharmaceuticals Inc (KALV) has scheduled its earnings report for Dec 11, 2025 before the markets open.
What is the KALV price-to-earnings (P/E) ratio?
KALV P/E ratio as of Nov 17, 2025 (TTM) is -3.45.
What is the KALV EPS forecast?
The forecasted EPS (Earnings Per Share) for KalVista Pharmaceuticals Inc (KALV) for the first fiscal quarter 2025 is -$1.06.
What are KalVista Pharmaceuticals Inc's retained earnings?
On its balance sheet, KalVista Pharmaceuticals Inc reported retained earnings of $1.43 million for the latest quarter ending Jul 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
